It is the first test the FDA has cleared for use in symptomatic adults aged 40 and over, according to C2N Diagnostics.

Genetic risk beyond APOE was linked to cognition, hippocampal volume, amyloid and tau across several ancestry groups.

According to the findings, these changes occurred at least seven years before amyloid plaques became visible on scans. The ...

Will getting a blood test for amyloid levels eventually form part of routine primary care health checks, or are we putting ...

Answer: Research advances are helping scientists better understand Alzheimer’s disease, but no single study has found a cure ...

Testing for Alzheimer’s-related brain changes has traditionally depended on procedures that can be expensive, invasive, or ...

A protein thought to play a critical role in the progression of Alzheimer’s disease may not originate where scientists ...

Alzheimer’s disease is linked with changes in the brain, including shrinking of areas involved in memory and accumulation of ...

A 2019 study found evidence of a bacteria linked to gum disease and its toxic enzymes in the brains of people with ...

A 74-year-old Grants Pass man with Alzheimer's has been missing since Wednesday morning without his medication.

Penn Holderness hopes his mom's Alzheimer's fight can help end the disease forever Penn Holderness joins The Lead.